Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

McKesson Corporation : McKesson and Epic Settle Patent Infringement Litigation

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/04/2013 | 08:11pm CEST


Settlement allows companies to focus on needs of customers

SAN FRANCISCO, March 4, 2013 - McKesson Corporation and Epic Systems Corporation have settled their longstanding patent infringement litigation involving McKesson's U.S. patent #6,757,898 and Epic's MyChart software. 

Under terms of the settlement, McKesson agreed to grant Epic a license to the patent for the benefit of Epic and its customers.  In exchange, Epic agreed that it will no longer contest the validity of the patent, allowing McKesson and Epic to return to normalcy in their relationship going forward.  The parties also agreed to dismiss all pending claims and counterclaims and end any further litigation and appeals.

Executives from both parties recognized the settlement as one that will benefit the healthcare industry in general, and allow both parties to focus on the needs of their customers. 

"We're delighted to have settled this litigation with McKesson," said Carl Dvorak, chief operating officer, Epic Systems Corporation.

"We look forward to reestablishing our prior relationship and exploring new opportunities to serve our mutual customers," echoed Jeff Felton, president of McKesson's RelayHealth business. "Both companies will benefit by putting this litigation behind us."

About McKesson Corporation

McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.www.mckesson.com.

PR Contact

Kris Fortner
415.983.8352
[email protected]



distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MCKESSON CORPORATION
09/20DJMakers Of Opioids Are Asked For Data -- WSJ
09/19DJStates Push Ahead With Investigation Into Opioid Painkillers
09/19 MCKESSON : Increases Hurricane Relief Commitment to $600,000
09/14 MCKESSON : MCK) Shares Rose, Shareholder Rockland Trust Co Decreased Its Holding..
09/14 CARDINAL HEALTH : Wave of Kentucky counties file lawsuits against drug distribut..
09/13 Hocking County joins the fight against the opioid distributors
09/13 CARDINAL HEALTH : Ten counties sue opioid distributors for 'creating a public nu..
09/12 MCKESSON : Hurricane Irma - McKesson Prepares to Support Healthcare Providers, P..
09/11 MCKESSON : How Effective Drug Packaging Improves Supply Chain Performance
09/11 MCKESSON : Successful Antibiotic Stewardship Relies on Prescribing Data
More news
News from SeekingAlpha
09/20 HIGH-CONVICTION BUYBACKS : McKesson
09/20 OWENS & MINOR : An Ugly First Half Supports A Short Case, Even At The Lows
09/19 State AGs gang up on opioid makers, 41 now in coalition
09/19 Premarket analyst action - healthcare coverage changes
09/19 Premarket analyst action - healthcare new coverage
Financials ($)
Sales 2018 206 B
EBIT 2018 3 675 M
Net income 2018 1 892 M
Debt 2018 3 485 M
Yield 2018 0,81%
P/E ratio 2018 17,53
P/E ratio 2019 15,92
EV / Sales 2018 0,17x
EV / Sales 2019 0,17x
Capitalization 32 079 M
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 171 $
Spread / Average Target 12%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
James A. Beer Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Marie L. Knowles Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION8.63%32 079
WALGREENS BOOTS ALLIANCE-4.74%83 682
CVS HEALTH0.82%80 878
EXPRESS SCRIPTS HOLDING CO-10.13%35 646
CARDINAL HEALTH INC-7.31%21 130
AMERISOURCEBERGEN CORP.1.68%17 612